| 1 | tumor | 17,708 |
| 2 | tumour | 4,082 |
| 3 | avascular | 139 |
| 4 | tumoral | 111 |
| 5 | fibrinoid | 25 |
| 6 | myeloid-derived | 25 |
| 7 | angiomyolipoma | 23 |
| 8 | comedo | 19 |
| 9 | hepatocytic | 10 |
| 10 | anchorage-dependent | 9 |
| 11 | anti-von | 5 |
| 12 | dn2 | 5 |
| 13 | endothelioma | 5 |
| 14 | leiomyomal | 5 |
| 15 | microcolony | 5 |
| 16 | comedo-type | 4 |
| 17 | 'tumour | 3 |
| 18 | budded | 3 |
| 19 | c1q/tumor | 3 |
| 20 | erythroblast | 3 |
| 21 | forl | 3 |
| 22 | myocardiocyte | 3 |
| 23 | r132h | 3 |
| 24 | tendon-like | 3 |
| 25 | th2/th17 | 3 |
| 26 | uninucleate | 3 |
| 27 | xanthoma/xanthelasma | 3 |
| 28 | a-tumor | 2 |
| 29 | age/maturity | 2 |
| 30 | dhbv | 2 |
| 31 | haight | 2 |
| 32 | hsp47-positive | 2 |
| 33 | ngf-treated | 2 |
| 34 | panendothelial | 2 |
| 35 | peri-anal | 2 |
| 36 | quantitive | 2 |
| 37 | steroid-avascular | 2 |
| 38 | tumor/metastasis | 2 |
| 39 | tumour- | 2 |
| 40 | 'nipple | 1 |
| 41 | -32/tumor | 1 |
| 42 | 1-v″ | 1 |
| 43 | anti–tumor | 1 |
| 44 | biflagellated | 1 |
| 45 | ca-125/recist | 1 |
| 46 | dysli | 1 |
| 47 | entero-gastric | 1 |
| 48 | ester-supplemented | 1 |
| 49 | examinations.surgical | 1 |
| 50 | five-tumour | 1 |
| 51 | foliated | 1 |
| 52 | full-layer | 1 |
| 53 | gastrinergic | 1 |
| 54 | hbv-tg/tumor | 1 |
| 55 | hcn1-rich | 1 |
| 56 | hormone-ischemic | 1 |
| 57 | ia-iiib | 1 |
| 58 | ib-ix/von | 1 |
| 59 | interleukin-6/tumor | 1 |
| 60 | length-fast | 1 |
| 61 | ligand/tumor | 1 |
| 62 | masses.frozen | 1 |
| 63 | metasatases | 1 |
| 64 | micro-colony | 1 |
| 65 | month-tumor | 1 |
| 66 | mortality-predictive | 1 |
| 67 | musculo-aponevrotic | 1 |
| 68 | neutrophil-induced | 1 |
| 69 | non-anti-tumor | 1 |
| 70 | oncogene-tumor | 1 |
| 71 | oncogenes/tumor | 1 |
| 72 | outcome-hernia | 1 |
| 73 | papilary | 1 |
| 74 | perforin-granzyme-dependent | 1 |
| 75 | phospholamban.tumour | 1 |
| 76 | post-disease | 1 |
| 77 | shrna-negative | 1 |
| 78 | south-to-north | 1 |
| 79 | time-to-radiological | 1 |
| 80 | tisular | 1 |
| 81 | tract-specific | 1 |
| 82 | traditional-bridging | 1 |
| 1 | 'nipple | 1 |
| 2 | 'tumour | 3 |
| 3 | -32/tumor | 1 |
| 4 | 1-v″ | 1 |
| 5 | a-tumor | 2 |
| 6 | age/maturity | 2 |
| 7 | anchorage-dependent | 9 |
| 8 | angiomyolipoma | 23 |
| 9 | anti-von | 5 |
| 10 | anti–tumor | 1 |
| 11 | avascular | 139 |
| 12 | biflagellated | 1 |
| 13 | budded | 3 |
| 14 | c1q/tumor | 3 |
| 15 | ca-125/recist | 1 |
| 16 | comedo | 19 |
| 17 | comedo-type | 4 |
| 18 | dhbv | 2 |
| 19 | dn2 | 5 |
| 20 | dysli | 1 |
| 21 | endothelioma | 5 |
| 22 | entero-gastric | 1 |
| 23 | erythroblast | 3 |
| 24 | ester-supplemented | 1 |
| 25 | examinations.surgical | 1 |
| 26 | fibrinoid | 25 |
| 27 | five-tumour | 1 |
| 28 | foliated | 1 |
| 29 | forl | 3 |
| 30 | full-layer | 1 |
| 31 | gastrinergic | 1 |
| 32 | haight | 2 |
| 33 | hbv-tg/tumor | 1 |
| 34 | hcn1-rich | 1 |
| 35 | hepatocytic | 10 |
| 36 | hormone-ischemic | 1 |
| 37 | hsp47-positive | 2 |
| 38 | ia-iiib | 1 |
| 39 | ib-ix/von | 1 |
| 40 | interleukin-6/tumor | 1 |
| 41 | leiomyomal | 5 |
| 42 | length-fast | 1 |
| 43 | ligand/tumor | 1 |
| 44 | masses.frozen | 1 |
| 45 | metasatases | 1 |
| 46 | micro-colony | 1 |
| 47 | microcolony | 5 |
| 48 | month-tumor | 1 |
| 49 | mortality-predictive | 1 |
| 50 | musculo-aponevrotic | 1 |
| 51 | myeloid-derived | 25 |
| 52 | myocardiocyte | 3 |
| 53 | neutrophil-induced | 1 |
| 54 | ngf-treated | 2 |
| 55 | non-anti-tumor | 1 |
| 56 | oncogene-tumor | 1 |
| 57 | oncogenes/tumor | 1 |
| 58 | outcome-hernia | 1 |
| 59 | panendothelial | 2 |
| 60 | papilary | 1 |
| 61 | perforin-granzyme-dependent | 1 |
| 62 | peri-anal | 2 |
| 63 | phospholamban.tumour | 1 |
| 64 | post-disease | 1 |
| 65 | quantitive | 2 |
| 66 | r132h | 3 |
| 67 | shrna-negative | 1 |
| 68 | south-to-north | 1 |
| 69 | steroid-avascular | 2 |
| 70 | tendon-like | 3 |
| 71 | th2/th17 | 3 |
| 72 | time-to-radiological | 1 |
| 73 | tisular | 1 |
| 74 | tract-specific | 1 |
| 75 | traditional-bridging | 1 |
| 76 | tumor | 17,708 |
| 77 | tumor/metastasis | 2 |
| 78 | tumoral | 111 |
| 79 | tumour | 4,082 |
| 80 | tumour- | 2 |
| 81 | uninucleate | 3 |
| 82 | xanthoma/xanthelasma | 3 |
| 1 | tumour- | 2 |
| 2 | dn2 | 5 |
| 3 | th2/th17 | 3 |
| 4 | outcome-hernia | 1 |
| 5 | endothelioma | 5 |
| 6 | angiomyolipoma | 23 |
| 7 | xanthoma/xanthelasma | 3 |
| 8 | ia-iiib | 1 |
| 9 | tract-specific | 1 |
| 10 | gastrinergic | 1 |
| 11 | hormone-ischemic | 1 |
| 12 | entero-gastric | 1 |
| 13 | musculo-aponevrotic | 1 |
| 14 | hepatocytic | 10 |
| 15 | neutrophil-induced | 1 |
| 16 | budded | 3 |
| 17 | ngf-treated | 2 |
| 18 | foliated | 1 |
| 19 | biflagellated | 1 |
| 20 | ester-supplemented | 1 |
| 21 | myeloid-derived | 25 |
| 22 | fibrinoid | 25 |
| 23 | tendon-like | 3 |
| 24 | 'nipple | 1 |
| 25 | comedo-type | 4 |
| 26 | post-disease | 1 |
| 27 | uninucleate | 3 |
| 28 | myocardiocyte | 3 |
| 29 | shrna-negative | 1 |
| 30 | mortality-predictive | 1 |
| 31 | hsp47-positive | 2 |
| 32 | quantitive | 2 |
| 33 | traditional-bridging | 1 |
| 34 | r132h | 3 |
| 35 | hcn1-rich | 1 |
| 36 | south-to-north | 1 |
| 37 | dysli | 1 |
| 38 | time-to-radiological | 1 |
| 39 | examinations.surgical | 1 |
| 40 | panendothelial | 2 |
| 41 | leiomyomal | 5 |
| 42 | peri-anal | 2 |
| 43 | tumoral | 111 |
| 44 | forl | 3 |
| 45 | masses.frozen | 1 |
| 46 | anti-von | 5 |
| 47 | ib-ix/von | 1 |
| 48 | comedo | 19 |
| 49 | avascular | 139 |
| 50 | steroid-avascular | 2 |
| 51 | tisular | 1 |
| 52 | full-layer | 1 |
| 53 | tumor | 17,708 |
| 54 | a-tumor | 2 |
| 55 | oncogene-tumor | 1 |
| 56 | month-tumor | 1 |
| 57 | non-anti-tumor | 1 |
| 58 | -32/tumor | 1 |
| 59 | interleukin-6/tumor | 1 |
| 60 | ligand/tumor | 1 |
| 61 | hbv-tg/tumor | 1 |
| 62 | c1q/tumor | 3 |
| 63 | oncogenes/tumor | 1 |
| 64 | anti–tumor | 1 |
| 65 | tumour | 4,082 |
| 66 | 'tumour | 3 |
| 67 | five-tumour | 1 |
| 68 | phospholamban.tumour | 1 |
| 69 | metasatases | 1 |
| 70 | tumor/metastasis | 2 |
| 71 | haight | 2 |
| 72 | anchorage-dependent | 9 |
| 73 | perforin-granzyme-dependent | 1 |
| 74 | length-fast | 1 |
| 75 | erythroblast | 3 |
| 76 | ca-125/recist | 1 |
| 77 | dhbv | 2 |
| 78 | micro-colony | 1 |
| 79 | microcolony | 5 |
| 80 | papilary | 1 |
| 81 | age/maturity | 2 |
| 82 | 1-v″ | 1 |